PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE
申请人:NORTH CAROLINA CENTRAL UNIVERSITY
公开号:US20160237058A1
公开(公告)日:2016-08-18
This invention relates generally to compounds that are glucuronidase inhibitors. The glucuronidase inhibitors include phenoxy thiophene sulfonamides, and other compounds such as pyridine sulfonyls, benzene sulfonyls, thiophene sulfonyls, thiazole sulfonyls, thiophene carbonyls, and thiazole carbonyls. These compounds include nialamide, isocarboxazid, phenelzine, amoxapine, loxapine and mefloquine. Also compositions including one or more of such compounds for use in inhibiting glucuronidase and methods of using one or more of such compounds for selective inhibition of bacterial β-glucoronidase. These compounds may be used as a co-drug in combination with the anticancer drug CPT-11. Also a method for screening compounds to determine their usefulness in reducing diarrhea associated with irinotecan chemotherapy.
本发明涉及一般与葡萄糖醛酸酶抑制剂有关的化合物。这些葡萄糖醛酸酶抑制剂包括苯氧基噻吩磺酰胺和其他化合物,例如吡啶磺酰基、苯磺酰基、噻吩磺酰基、噻唑磺酰基、噻吩羰基和噻唑羰基。这些化合物包括尼氨胺、异卡泊嗪、苯妥英、阿莫西平、洛西平和美氟喹。此外,还包括含有一种或多种此类化合物的组合物,用于抑制葡萄糖醛酸酶,并使用一种或多种此类化合物进行细菌β-葡萄糖醛酸酶的选择性抑制的方法。这些化合物可作为联合抗癌药物CPT-11的辅助药物使用。还包括一种筛选化合物的方法,以确定它们在减少伊立替康化疗引起的腹泻方面的有用性。